Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
about
Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapRace, healthcare access and physician trust among prostate cancer patientsTrends in the treatment of localized prostate cancer using supplemented cancer registry data.A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men.Use of androgen deprivation therapy for metastatic prostate cancer in older men.Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differencesQuantifying the role of PSA screening in the US prostate cancer mortality decline.Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.Men's perspectives on selecting their prostate cancer treatmentRacial variation in the cost-effectiveness of chemotherapy for prostate cancer.Variation in quality of care among older men with localized prostate cancerInteractions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleVertebral fractures and the misclassification of osteoporosis in men with prostate cancerIncreasing use of observation among men at low risk for prostate cancer mortality.Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratificatRacial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?Disparities in Receipt of Radiotherapy and Survival by Age, Sex, and Ethnicity among Patient with Stage I Follicular LymphomaA new approach to understanding racial disparities in prostate cancer treatment.Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States.Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.Racial variation in the quality of surgical care for prostate cancer.Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina.Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.Access to information sources and treatment considerations among men with local stage prostate cancer.Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy.Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.Prostate cancer in men of African origin.Is prostate cancer different in black men? Answers from 3 natural history models.Religious Coping and Types and Sources of Information Used in Making Prostate Cancer Treatment Decisions.National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Geographical Factors Associated With Health Disparities in Prostate Cancer.Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?Radiotherapy and survival in prostate cancer patients: a population-based study.Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma.
P2860
Q33526534-7836FB69-1112-473C-88EA-3E8560F6A4EBQ33606053-CE845402-607D-4162-9C30-9FF6012A4EDDQ33610509-B1017ECF-7023-4B0E-94D0-95D8EBDB9F2DQ33671198-F91600A9-16F9-401A-8D43-4307E698662BQ33796424-922F6EFE-6B58-4A3C-826B-7F4A17B62F7AQ33977514-3FEB3C61-9191-44A3-9151-07602BDBA2A9Q34615251-5502FAAA-7EAF-4BCC-9DCB-B1DD0C4A15DDQ34720042-4B01EDAB-323F-46C8-9A77-15032ABBCDB7Q34728048-51CB2E5A-97D6-4CB0-B9E2-4C6CA78C13E7Q34817192-0ECDEC84-34ED-41A6-A904-894F85604BE9Q34974133-93C6EA1D-C106-4F21-B0FA-C15990716A94Q35069577-2033B749-FA3A-44B9-85F2-5E4CBCAAAAACQ35144499-59D0FC56-08E0-412D-8732-4D3241AE7479Q35147527-8619F027-0875-4FF0-B4F8-647B5B0F2C4EQ35186071-FF13D552-10D1-4E6E-AE7D-D9444C0CE8C5Q35955484-9A32060D-D516-42C1-8BB5-09903F52979BQ36133745-A5533AD1-4682-4A18-8BC6-C8EF705F0EADQ36421159-93191777-4C5D-461C-A008-29CFB1104E92Q36503071-DF8B6A6E-D5CB-4A9F-A2AA-E38A608EA3FAQ36845119-DBF84356-3A52-481D-9454-9BAAF767CA03Q36971869-95EDAF84-58DA-46F9-B23C-9C51D9BB5D34Q37115967-6A9C3BE2-AE2C-46F9-A407-D005583FC1D3Q37121645-79CE3A5C-B4D7-409E-9FB7-1EC09DE51E14Q37149323-7ABE1A08-02CC-4C80-AD6E-880D5D0A375FQ37152796-1F2AA360-16E7-4F7D-A51D-7985FFF02CE7Q37164773-06596CDC-62C9-492B-AA3E-6627ADB96C8DQ37178150-75578670-FB4E-4239-B212-304310585936Q37246641-EA2EEA5B-A786-4876-B296-9B5795BB9249Q37356222-CDEBCF6D-89AB-4816-9DDC-8A60960FF211Q37361918-0566D6BB-F622-41B9-BB01-539035246ACBQ37467475-2A988EAF-E89E-4D98-83EC-C1ED16015318Q37470630-42A74EE8-2CD7-49FC-9BC3-EC0CEE1738C6Q38683379-25FD4506-7FCF-4321-9560-2D7DC2F55E6EQ38823794-6B6852A2-5FA3-4506-8B01-3CC8F5131C80Q38963699-1F4C8823-BFE6-47F6-A7E3-1CC5A7CAA0D7Q39585300-D49C4FEA-153D-41D7-8240-2AD655497C42Q40476413-9658B832-76EF-4442-87DD-007F2D1417B9Q40566372-A1255F22-9865-4B83-89E6-D2595A0115DBQ42552729-B33C6CBA-8BBF-40EB-BBE5-60AE9533BB98Q44492875-618DD11C-FCEE-4B48-8C6B-CDE25A638632
P2860
Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@en
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@nl
type
label
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@en
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@nl
prefLabel
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@en
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@nl
P2093
P1433
P1476
Racial disparity in primary an ...... -Medicare trends 1991 to 1999.
@en
P2093
Arnold L Potosky
Ruth Etzioni
Scott D Ramsey
Steven B Zeliadt
P304
P356
10.1016/J.UROLOGY.2004.07.037
P407
P577
2004-12-01T00:00:00Z